...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients
【24h】

Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients

机译:交叉匹配HLA不相容的阳性移植受者的肾脏同种异体移植物病理变化的时程

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Recipients of incompatible allografts are at increased risk of graft loss. We hypothesized that analysis of sequential biopsies from these grafts could define progression of graft lesions and identify features predictive of progression. METHODS: We studied the time course of histologic injury in 745 kidney graft biopsies from 129 patients transplanted with a positive crossmatch human leukocyte antigen-incompatible kidney between 2000 and 2010 (follow-up of 1-9 years). RESULTS: Graft survival was 98% at 1 year and 80% at 5 years after transplantation. Throughout follow-up, 70% of patients experienced rejection, with 52% showing subclinical rejection in the first year. Cell-mediated rejection was more frequent than antibody-mediated rejection throughout follow-up. Transplant glomerulopathy (TxGN; cg≥1) developed in 47% of patients over the period of the study, as early as 3 months in a few patients. TxGN was preceded by glomerulitis in more than 90% of cases, with a median time interval of 12 months. Glomerulitis and detectable posttransplantation donor-specific antibodies were risk factors for TxGN (P<0.0001 and P<0.05). C4d-negative antibody-mediated rejection manifesting as capillaritis (g≥1 and ptc≥1) with detectable donor-specific antibodies was observed in some recipients (<20%). There was progressively higher average tubulointerstitial scarring (ci+ct) from 3 to 6 to 12 months (P<0.001). CONCLUSIONS: Despite good graft survival, a significant incidence of biopsy-proven rejection occurred in this subset of closely monitored human leukocyte antigen-incompatible recipients throughout follow-up. Microcirculation inflammation, particularly glomerulitis, irrespective of C4d, is associated with a high risk of development of TxGN at 1 year.
机译:背景:不相容同种异体移植接受者的移植物丢失风险增加。我们假设对这些移植物进行连续活检的分析可以确定移植物病变的进展并确定可预测进展的特征。方法:我们研究了2000年至2010年之间745例肾移植活检的组织学损伤的时程,这些患者的129例患者移植了具有交叉匹配的人类白细胞抗原不相容的阳性肾脏(随访期1-9年)。结果:移植后1年移植存活率为98%,5年移植存活率为80%。在整个随访过程中,第一年有70%的患者出现排斥反应,其中52%的患者表现出亚临床排斥反应。在整个随访过程中,细胞介导的排斥反应比抗体介导的排斥反应更为频繁。在研究期间,移植肾小球病变(TxGN;cg≥1)的患者中占47%,少数患者最早出现3个月。超过90%的病例在TxGN之前发生肾小球炎,中位时间间隔为12个月。肾小球炎和可检测的移植后供体特异性抗体是TxGN的危险因素(P <0.0001和P <0.05)。在一些接受者中,观察到C4d阴性抗体介导的排斥反应,表现为毛细血管炎(g≥1和ptc≥1),且可检测到供体特异性抗体(<20%)。在3至6至12个月内,平均肾小管间质瘢痕形成(ci + ct)逐渐升高(P <0.001)。结论:尽管移植物存活良好,但在整个随访过程中,这一受密切监测的人类白细胞抗原不相容受体的亚组中发生了经活检证实的排斥反应的发生率很高。微循环炎症,尤其是肾小球炎,与C4d无关,与1年时发生TxGN的高风险相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号